| Class / Patent application number | Description | Number of patent applications / Date published |
|---|
| 424607000 | Hydrogen metal cyanide, cyanide, cyanate, or thio analog thereof | 9 |
| 20100247673 | Thyroid protection in sickle cell anemia treatment - In a method of providing anti-sickling of red blood cells in sickle cell anemia patients without hemolyzing the cells comprising, administering in a pharmaceutically acceptable vehicle an anti-sickling, non-hemolyzing amount of thiocyanate selected from the group consisting of alkali metal salts and an ammonium salt until the Hbss relative solubility ratio is at least 1.200 in the deoxygenated hemoglobin-S, the improvement of protecting the thyroid gland in the event of thiocyanate overdose, comprising administering along with the thiocyanate in the pharmaceutically acceptable vehicle, iodine in an amount sufficient to prevent thiocyanate overdose. | 09-30-2010 |
| 20120034313 | Microbiocide/Sulfide Control Blends - A chemical blend that simultaneously kills bacteria and suppresses the production of hydrogen sulfide (H | 02-09-2012 |
| 20120328709 | METHODS OF DISSOLVING BLOOD CLOTS AND THE LIKE - The present invention provides an aqueous composition and its use for dissolving blood clots in vivo or in clinical or research samples in vitro, said composition comprising at least one chaotropic agent, at least one chelating agent that complexes iron if the chaotropic agent does not complex iron and at least one surface-active emulsifier, the composition being buffered near pH 7.4. The process of dissolving the clot with the aqueous composition is advantageous because it is simple, inexpensive, rapid and can be applied in a variety of contexts, including basic research and clinical situations. | 12-27-2012 |
| 424608000 | Heavy metal containing (e.g., nitroprusside, etc.) | 4 |
| 20100233288 | MEDICAL DEVICES CONTAINING NITROPRUSSIDE AND ANTIMICROBIAL AGENTS - A medical device includes a structure configured for introduction to a vascular system of a patient. The structure including a surface having sodium nitroprusside and silver disposed thereupon. The sodium nitroprusside has a concentration sufficient to reduce thrombosis. To make the medical device, a base material is impregnated with sodium nitroprusside, the medical device is formed from the base material, and the medical device is coated with an antimicrobial agent. | 09-16-2010 |
| 20100303926 | ORGANIC COMPOUNDS - The present invention relates to compounds of the general formula (I) and the salts thereof, preferably the pharmaceutically acceptable salts thereof; in which in which R | 12-02-2010 |
| 20110300232 | EFFECTS OF NITRIC OXIDE (NO) AND iNOS ON EXPRESSION AND SIGNAL TRANSDUCTION IN CANCER AND ITS USE IN DRUG DISCOVERY AND CANCER THERAPY DESIGN - Nitric Oxide (NO) acts as double-edged sword, which induces and prevents cell death, depending on various factors. The mechanism for the NO regulation of cells is not fully understood. The present invention provides experiment design methods and therapy design methods leveraging viable hypothesis supported by current research findings. This invention determines the effects of NO by controlling the majority parameters such as the steady-state concentration of NO, duration of NO exposure and the local level of oxygen. The experiment designs are structured to improve understanding of NO regulation of cells, and further can be directly adapted for therapy design. The invention directs these experiment design and therapy design methods to the study and treatment of cancer. In an application, the effects of exogenous NO on inducible Nitric Oxide Synthase (iNOS) expression and signal transduction in ovarian cancer is applied to drug discovery and therapy design for ovarian and other cancers. | 12-08-2011 |
| 20140271916 | MULTIVALENCE PHOTOCATALYTIC SEMICONDUCTOR ELEMENTS - Described herein are elements comprising a p-type semiconductor comprising mixed valence oxide compounds and an n-type semiconductor having a deeper valence band than the p-type semiconductor valence bands wherein the semiconductor types are in ionic communication with each other. The elements enhance photocatalytic activity. | 09-18-2014 |
| 424610000 | Potassium or lithium containing | 2 |
| 20120058199 | COMPOSITIONS, USE AND METHOD FOR THE USE OF SURFACE ACTIVE PROTEINS IN TOPICAL DRUG DELIVERY ACROSS KERATIN - The present invention provides the use of surface active proteins, especially class I and class II hydrophobins, in topically applied pharmaceutical formulations. The invention is particularly directed to topically applied pharmaceutical products for enhancing the penetration to achieve a transungual delivery of a prophylactically and/or therapeutically effective amount of an active ingredient (drug) to a patient (including animals and humans) into and/or through a nail, of the animal or human body, in order to treat one or more of a variety of diseases or disorders. Related embodiments of the invention are also disclosed. | 03-08-2012 |
| 20130089620 | COMPOSITION COMPRISING A SOLID STATE HYPOTHIOCYANITE SALT OF A CATION - A solid composition is provided herein comprising at least one hypothiocyanite salt (OSCN—) of a cation in an amorphous and/or crystalline powder form. Also provided herein are methods of making the composition and methods of treating various conditions, such as airborne infection, lower respiratory tract infection or upper respiratory tract infection. | 04-11-2013 |
